|
|||||
|
|

Business development company Oaktree Specialty Lending (NASDAQ:OCSL) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 13.3% year on year to $75.1 million. Its non-GAAP profit of $0.41 per share was 8.8% above analysts’ consensus estimates.
Is now the time to buy OCSL? Find out in our full research report (it’s free for active Edge members).
Oaktree Specialty Lending’s fourth quarter saw a positive market reaction, despite a notable year-over-year decline in sales and a significant miss on non-GAAP profit. Management highlighted disciplined capital deployment and an uptick in new investment activity as offsets to headwinds from interest rate changes and ongoing nonaccrual challenges. President Matt Pendo pointed to stable earnings, stating, “We fully covered our quarterly dividend with earnings,” and stressed the importance of converting non-earning assets into income-generating investments, particularly as the rate environment shifted after the September cut.
Looking ahead, Oaktree Specialty Lending’s management is focused on leveraging its global platform to source deals in resilient sectors and manage risks tied to technology disruption, especially in software. CEO Armen Panossian emphasized selectivity in underwriting, particularly as artificial intelligence introduces both opportunity and uncertainty for software borrowers. Panossian noted, “We are prioritizing loans to businesses with resilient models, defensible market positions, and durable long-term outlooks.” Management also identified a potential increase in middle-market M&A activity and a cautious approach to payment-in-kind structures as important themes for the upcoming year.
Management attributed the quarter’s results to strong deployment in large-cap sponsor deals, portfolio repositioning, and a focus on first lien senior secured loans amid evolving credit market dynamics.
Oaktree Specialty Lending expects performance to be shaped by sector selectivity, the pace of middle-market deal activity, and disciplined risk management amid macro and technological shifts.
In the coming quarters, our analysts will be watching (1) Oaktree Specialty Lending’s ability to sustain deal flow in large and upper middle-market sponsor transactions, (2) the pace at which nonaccrual and underperforming assets are converted back to income-generating status, and (3) the impact of AI and technological disruption on the portfolio’s software holdings. Progress in managing rate-related headwinds and maintaining portfolio diversification will also be key signposts.
Oaktree Specialty Lending currently trades at $12.59, up from $12.14 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| Apr-17 | |
| Apr-02 | |
| Feb-11 | |
| Feb-06 | |
| Feb-05 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-02 | |
| Jan-29 | |
| Jan-08 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite